High Expression of MICA in Human Kidney Cancer Tissue and Renal Cell Carcinoma Lines |
Jia, Hong-Ying
(Department of Evidence-Based Medicine, The Second Hospital, Shandong University)
Liu, Jun-Li (Clinical Molecular Biology Laboratory, The Second Hospital, Shandong University) Zhou, Cheng-Jun (Department of Pathology, The Second Hospital, Shandong University) Kong, Feng (Central Research Laboratory, The Second Hospital, Shandong University) Yuan, Ming-Zhen (Department of Urology, The Second Hospital, Shandong University) Sun, Wen-Dong (Department of Urology, The Second Hospital, Shandong University) Wang, Jue (Central Research Laboratory, The Second Hospital, Shandong University) Liu, Ling (Clinical Molecular Biology Laboratory, The Second Hospital, Shandong University) Zhao, Jing-Jie (Clinical Molecular Biology Laboratory, The Second Hospital, Shandong University) Luan, Yun (Central Research Laboratory, The Second Hospital, Shandong University) |
1 | Wu JD, Higgins LM, Steinle A, et al (2004). Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest, 114, 560-8. DOI |
2 | Yang F, Shao Y, Yang F, et al (2013). Valproic acid upregulates NKG2D ligand expression and enhances susceptibility of human renal carcinoma cells to NK cell-mediated cytotoxicity. Arch Med Sci, 9, 323-31. |
3 | Ye YB, Zhou ZF, Chen Q, et al (2008). The roles of soluble MICA in immune escape of breast tumor. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 24, 904-8 (Article in Chinese). |
4 | Bauer S, Groh V, Wu J, et al (1999). Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science, 285, 727-9. DOI ScienceOn |
5 | Busche A, Goldmann T, Naumann U, et al (2006). Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A. Hum Gene Ther, 17, 135-46. DOI ScienceOn |
6 | Cohen HT and McGovern FJ (2005). Renal-cell carcinoma. N Engl J Med, 353, 2477-90. DOI ScienceOn |
7 | Diefenbach A and Raulet DH (2002). The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol Rev, 188, 9-21. DOI ScienceOn |
8 | Doubrovina ES, Doubrovin MM, Vider E (2003). Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol, 171, 6891-9. DOI |
9 | Raffaghello L, Prigione I, Airoldi I, et al (2004). Down regulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia, 6, 558-68. DOI ScienceOn |
10 | Herberman RB, Nunn ME, Lavrin DH (1975). Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer, 16, 216-29. DOI |
11 | Mrozek E, Anderson P, Caligiuri MA (1996). Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood, 87, 2632-40. |
12 | Pardoll DM (2001). Immunology. Stress, NK receptors, and immune surveillance. Science, 294, 534-6. DOI ScienceOn |
13 | Sconocchia G, Spagnoli GC, Del Principe D, et al (2009). Defective infiltration of natural killer cells in MICA/Bpositive renal cell carcinoma involves beta (2)-integrinmediated interaction. Neoplasia, 11, 662-71. DOI |
14 | Weissinger D, Tagscherer KE, Macher-Goppinger S, et al (2013). The soluble Decoy receptor 3 is regulated by a PI3Kdependent mechanism and promotes migration and invasion in renal cell carcinoma. Mol Cancer, 12, 120. DOI ScienceOn |
15 | Diefenbach A, Jensen ER, Jamieson AM, Raulet DH (2001). Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature, 413, 165-71. DOI ScienceOn |